Drugs for managing diabetic neuropathy are similarly effective, yet the costs of these drugs vary greatly, according to a study in the Annals of Internal Medicine. The researchers conclude that prescribers should consider costs of the drug and other conditions the patient has when deciding what to prescribe. Read more and read the study abstract.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder